Sartorius collaborates to support global supply of coronavirus vaccines

Dow, Sartorius and Südpack Medica, have come together to support the global coronavirus vaccination effort by manufacturing bioprocessing bags, which are an essential component for the safe production and transportation of coronavirus vaccines globally. Dow, alongside Sartorius, a leading international partner of life science research and the biopharmaceutical industry, and packaging company Südpack, are each contributing innovative solutions and expertise in a collaborative value chain effort, to support the demands of the global vaccine supply and to ensure vaccines arrive to those in need quickly and safely. Sterile bioreactor bags with a capacity of up to 2 litres, made from multilayer films, can help to achieve outstanding speed, quality, and flexibility in the vaccine development process as well as in commercial manufacturing operations.